Aquestive Therapeutics, Inc. AQST Business Segments — Total General and Administrative Expenses

Similar metrics at other companies

SUPNReportable Segment — General and administrative expenses

$38.2M+43.2%

NSAReportable Segment — General and administrative expenses

$13.23M+0.7%

CRCTotal Reportable Segments — General and administrative expenses

$26M+73.3%

CTEVReportable Segment — General and administrative expenses

$57.83M+23.1%

SNDAReportable Segment — General and administrative expense

$10.46M+23.5%

JAN

JANTotal Reportable Segments — General And Administrative Expense

$5.07M+167%

Questions, answered.

What is Aquestive Therapeutics, Inc.'s business segments — total general and administrative expenses?

Aquestive Therapeutics, Inc. (AQST) reported business segments — total general and administrative expenses of $9.06M in Q1 2026.

How has Aquestive Therapeutics, Inc.'s business segments — total general and administrative expenses changed year-over-year?

Aquestive Therapeutics, Inc.'s business segments — total general and administrative expenses decreased by 43.8% year-over-year, from $16.12M to $9.06M.

What is the long-term trend for Aquestive Therapeutics, Inc.'s business segments — total general and administrative expenses?

Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s business segments — total general and administrative expenses has grown at a 42.8% compound annual growth rate (CAGR), from $30.11M to $61.37M.

What does business segments — total general and administrative expenses mean?

Includes the overhead costs necessary to support the segment's operations, such as executive management, legal, human resources, and corporate infrastructure. These expenses represent the fixed cost burden required to maintain the business unit's functional capacity. Tracking this metric is essential for evaluating the segment's operational leverage and cost discipline.